Drug Research
BioBlocks, Full Spectrum to develop new small molecule therapeutics
Full Spectrum Genetics and BioBlocks have signed an agreement to find new Small Molecule Therapeutics for protein-protein interactions. As part of the agreement, Full Spectrum Genetics protein analysis and engineering platform, MapEng, and BioBlocks'...
Drug Research
Mylan receives FDA approval for generic Lipitor ANDA
Mylan Laboratories, formerly Matrix Laboratories, has gained final FDA approval for its abbreviated new drug application (ANDA) of Atorvastatin Calcium Tablets of strengths 10mg, 20mg, 40mg and 80mg. The company begins immediate shipment of...
Drug Research
Cellectricon introduces Cellaxess discovery platform
Cellectricon has launched a new Cellaxess elektra discovery platform for automated electric field manipulation of adherent cells. Developed in collaboration with pharma and biotechnology companies, the Cellaxess platform enables scalable field stimulation, compound delivery...
Drug Research
Aegis wins US patent for octreotide formulations
Aegis Therapeutics has received US patent covering pharmaceutical composition of octreotide. The octreotide formulations incorporate Aegis' Intravail/ProTek excipients suitable for all routes of administration including oral, buccal, metered nasal spray, or injection. The Intravail/ProTek...
Drug Research
Cellectis introduces human iPS derived hepatocyte product
Cellectis stem cells, a business unit of Cellectis Group, has introduced hiPS-HEP, a human iPS derived hepatocyte product. The hiPS-HEP, with homogeneity, a long life span of stable CYP activity and reproducibility, provides a...
Drug Research
Antares, Watson Pharmaceuticals launch Gelnique 3% in US
Antares Pharma and Watson Pharmaceuticals have introduced Gelnique 3% (oxybutynin) gel 3%, for the treatment of overactive bladder. The product is available in a metered pump dispenser and is delivered transdermally, resulting in a...
Drug Research
Meridian, Teva settle epinephrine auto-injector pending patent litigation
Meridian Medical Technologies, a Pfizer subsidiary, and Teva have entered into a settlement agreement to resolve generic epinephrine auto-injector pending patent litigation. Under the terms of the agreement, Teva may launch a generic epinephrine...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
